
Pancham Bakshi
Examiner (ID: 13798, Phone: (571)270-3463 , Office: P/1671 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1621, 1671, 1623, 1673 |
| Total Applications | 1518 |
| Issued Applications | 1042 |
| Pending Applications | 137 |
| Abandoned Applications | 365 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16930779
[patent_doc_number] => 20210196668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => TIGLIEN-3-ONE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/204747
[patent_app_country] => US
[patent_app_date] => 2021-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16716
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17204747
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/204747 | TIGLIEN-3-ONE DERIVATIVES | Mar 16, 2021 | Abandoned |
Array
(
[id] => 20993302
[patent_doc_number] => 12741921
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-09-22
[patent_title] => Process for the production of ethyl tertiary butyl ethers
[patent_app_type] => utility
[patent_app_number] => 18/273744
[patent_app_country] => US
[patent_app_date] => 2021-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 3268
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18273744
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/273744 | PROCESS FOR THE PRODUCTION OF ETHYL TERTIARY BUTYL ETHERS | Mar 16, 2021 | Pending |
Array
(
[id] => 18449339
[patent_doc_number] => 20230190615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => COMPOSITIONS COMPRISING RHAMNOLIPID, ALKYL POLYGLYCOSIDE AND ACYL LACTYLATE
[patent_app_type] => utility
[patent_app_number] => 17/907015
[patent_app_country] => US
[patent_app_date] => 2021-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4397
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907015
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/907015 | COMPOSITIONS COMPRISING RHAMNOLIPID, ALKYL POLYGLYCOSIDE AND ACYL LACTYLATE | Mar 15, 2021 | Pending |
Array
(
[id] => 17141620
[patent_doc_number] => 20210309632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => 4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/203146
[patent_app_country] => US
[patent_app_date] => 2021-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14381
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17203146
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/203146 | Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators | Mar 15, 2021 | Issued |
Array
(
[id] => 18664813
[patent_doc_number] => 11771678
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Therapeutic agent for neuropathy in organic acidemia of which mechanism relies on increase in cAMP
[patent_app_type] => utility
[patent_app_number] => 17/198904
[patent_app_country] => US
[patent_app_date] => 2021-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 7680
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17198904
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/198904 | Therapeutic agent for neuropathy in organic acidemia of which mechanism relies on increase in cAMP | Mar 10, 2021 | Issued |
Array
(
[id] => 17082019
[patent_doc_number] => 20210277025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => BIONANOCOMPOSITE AND METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/196233
[patent_app_country] => US
[patent_app_date] => 2021-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4205
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17196233
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/196233 | BIONANOCOMPOSITE AND METHOD THEREOF | Mar 8, 2021 | Abandoned |
Array
(
[id] => 16913790
[patent_doc_number] => 20210186882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => FREEZE-DRIED ALGINIC ACID PREPARATION
[patent_app_type] => utility
[patent_app_number] => 17/194742
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194742
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/194742 | FREEZE-DRIED ALGINIC ACID PREPARATION | Mar 7, 2021 | Abandoned |
Array
(
[id] => 18434443
[patent_doc_number] => 20230181737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => ENTEROENDOCRINE CELL-TARGETING POLYMER SUBSTANCE CONJUGATED WITH PHOTOSENSITIZER, AND MEDICAL USE THEREOF FOR AMELIORATING METABOLIC DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/926496
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7691
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17926496
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/926496 | ENTEROENDOCRINE CELL-TARGETING POLYMER SUBSTANCE CONJUGATED WITH PHOTOSENSITIZER, AND MEDICAL USE THEREOF FOR AMELIORATING METABOLIC DISEASE | Mar 7, 2021 | Pending |
Array
(
[id] => 20922120
[patent_doc_number] => 12717176
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-08-25
[patent_title] => Compound and optical film comprising same
[patent_app_type] => utility
[patent_app_number] => 17/795370
[patent_app_country] => US
[patent_app_date] => 2021-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 8
[patent_no_of_words] => 22640
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17795370
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/795370 | COMPOUND AND OPTICAL FILM COMPRISING SAME | Mar 3, 2021 | Pending |
Array
(
[id] => 17065792
[patent_doc_number] => 20210268007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => TREATMENT OF TRIPLE NEGATIVE BREAST CANCER
[patent_app_type] => utility
[patent_app_number] => 17/190317
[patent_app_country] => US
[patent_app_date] => 2021-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10079
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17190317
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/190317 | Pivarubicin and benzarubicin compositions | Mar 1, 2021 | Issued |
Array
(
[id] => 16898971
[patent_doc_number] => 20210177887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING ELASTIC FIBER BREAKDOWN
[patent_app_type] => utility
[patent_app_number] => 17/185482
[patent_app_country] => US
[patent_app_date] => 2021-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17185482
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/185482 | COMPOSITIONS AND METHODS FOR TREATING ELASTIC FIBER BREAKDOWN | Feb 24, 2021 | Abandoned |
Array
(
[id] => 16913906
[patent_doc_number] => 20210186998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/185734
[patent_app_country] => US
[patent_app_date] => 2021-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20461
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17185734
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/185734 | COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS | Feb 24, 2021 | Abandoned |
Array
(
[id] => 18255434
[patent_doc_number] => 20230082473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => METHOD FOR REDUCING NUCLEIC ACID AND ADSORBING FILTER
[patent_app_type] => utility
[patent_app_number] => 17/801715
[patent_app_country] => US
[patent_app_date] => 2021-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14366
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17801715
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/801715 | METHOD FOR REDUCING NUCLEIC ACID AND ADSORBING FILTER | Feb 18, 2021 | Pending |
Array
(
[id] => 19778505
[patent_doc_number] => 12227529
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-18
[patent_title] => Method of preparing silanols with selective cytochrome P450 variants and related compounds and compositions
[patent_app_type] => utility
[patent_app_number] => 17/800211
[patent_app_country] => US
[patent_app_date] => 2021-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 32
[patent_no_of_words] => 20791
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17800211
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/800211 | Method of preparing silanols with selective cytochrome P450 variants and related compounds and compositions | Feb 18, 2021 | Issued |
Array
(
[id] => 17035074
[patent_doc_number] => 20210252032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => DRUGS FOR GRP78 CELL SURFACE TRANSLOCATION AND PAR-4 SECRETION
[patent_app_type] => utility
[patent_app_number] => 17/178096
[patent_app_country] => US
[patent_app_date] => 2021-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2507
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17178096
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/178096 | Drugs for GRP78 cell surface translocation and Par-4 secretion | Feb 16, 2021 | Issued |
Array
(
[id] => 20432531
[patent_doc_number] => 12502403
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-23
[patent_title] => Tafoxiparin for the treatment of preeclampsia
[patent_app_type] => utility
[patent_app_number] => 17/800131
[patent_app_country] => US
[patent_app_date] => 2021-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6722
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17800131
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/800131 | Tafoxiparin for the treatment of preeclampsia | Feb 15, 2021 | Issued |
Array
(
[id] => 16946554
[patent_doc_number] => 20210205245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => LIPOSOMAL ANTICANCER COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/174291
[patent_app_country] => US
[patent_app_date] => 2021-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17174291
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/174291 | LIPOSOMAL ANTICANCER COMPOSITIONS | Feb 10, 2021 | Abandoned |
Array
(
[id] => 16870049
[patent_doc_number] => 20210163516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => Complexes
[patent_app_type] => utility
[patent_app_number] => 17/173500
[patent_app_country] => US
[patent_app_date] => 2021-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20537
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17173500
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/173500 | Complexes | Feb 10, 2021 | Issued |
Array
(
[id] => 20158191
[patent_doc_number] => 12384803
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-12
[patent_title] => Non-cryogenic synthesis of heteroatom-bridge precursors of metal-ligand complex catalysts
[patent_app_type] => utility
[patent_app_number] => 17/801628
[patent_app_country] => US
[patent_app_date] => 2021-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4041
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17801628
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/801628 | Non-cryogenic synthesis of heteroatom-bridge precursors of metal-ligand complex catalysts | Feb 9, 2021 | Issued |
Array
(
[id] => 17007040
[patent_doc_number] => 20210238201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/166138
[patent_app_country] => US
[patent_app_date] => 2021-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12364
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17166138
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/166138 | ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS | Feb 2, 2021 | Abandoned |